Search research articles
Contact Us
Filters
Showing results (181-190 of 197) with videos related to
Page
of 20
Sort By:
The Lancet Regional Health. Europe
|
May 3, 2023
Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study
David M G Halpin, Andrew P Dickens, Derek Skinner, et al.
The European Respiratory Journal
|
March 9, 2019
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
Dave Singh, Alvar Agusti, Antonio Anzueto, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 28, 2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Claus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
Respirology (Carlton, Vic.)
|
February 3, 2017
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
The European Respiratory Journal
|
February 10, 2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
Archivos De Bronconeumologia
|
March 10, 2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus F Vogelmeier, Gerard J Criner, Fernando J Martínez, et al.
Archivos De Bronconeumologia
|
July 3, 2017
Erratum to "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary" [Arch Bronconeumol. 2017;53:128-49]
Claus F Vogelmeier, Gerard J Criner, Fernando J Martínez, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
November 6, 2020
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions
Arnaud Bourdin, Gerard Criner, Gilles Devouassoux, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 30, 2026
How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD
Alvar Agusti, Marc Vila, Rosa Faner, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 1, 2026
Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients
David W Denning, Thomas R Rogers, Takahiro Takazono, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 197) with videos related to
Sort By:
Page
of 20
The Lancet Regional Health. Europe
|
May 3, 2023
Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study
David M G Halpin, Andrew P Dickens, Derek Skinner, et al.
The European Respiratory Journal
|
March 9, 2019
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
Dave Singh, Alvar Agusti, Antonio Anzueto, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 28, 2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Claus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
Respirology (Carlton, Vic.)
|
February 3, 2017
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
The European Respiratory Journal
|
February 10, 2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus F Vogelmeier, Gerard J Criner, Fernando J Martinez, et al.
Archivos De Bronconeumologia
|
March 10, 2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus F Vogelmeier, Gerard J Criner, Fernando J Martínez, et al.
Archivos De Bronconeumologia
|
July 3, 2017
Erratum to "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary" [Arch Bronconeumol. 2017;53:128-49]
Claus F Vogelmeier, Gerard J Criner, Fernando J Martínez, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
November 6, 2020
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions
Arnaud Bourdin, Gerard Criner, Gilles Devouassoux, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 30, 2026
How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD
Alvar Agusti, Marc Vila, Rosa Faner, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 1, 2026
Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients
David W Denning, Thomas R Rogers, Takahiro Takazono, et al.
Page
of 20